Dr. Sam Williams

Sam is Managing Partner, Life Sciences, at IP Group. Sam has more than 25 years of experience in the biotechnology industry, both as a top-ranked equity analyst in London, and subsequently, as an investor and chief executive. He is Founder and Executive Chairman of Istesso Limited, a Phase 2 drug-discovery company, and oversees the Life Sciences portfolio for the FTSE250 company IP Group plc. He serves as a Non-Executive Director of Diurnal Group plc, Microbiotica Ltd, Psioxus Ltd, and Kuur Therapeutics Ltd.

Sam holds a Ph.D. in molecular biology from the University of Cambridge and a degree in biology from the University of Oxford.